(Circulation. 1997;96:1944-1952.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Medicine (R.W., J.C.R., K.A.R., G.D.C., N.A.S., S.B.K., J.N.W.) and the Department of Radiation Oncology (I.R.C.), Emory University School of Medicine, Atlanta, Ga. Dr Waksman is now at the Cardiology Research Foundation, Washington, DC.
Correspondence to Josiah N. Wilcox, PhD, Emory University, Department of Medicine, Division of Hematology/Oncology, 1639 Pierce Dr, Room 1115 WMRB, Atlanta, GA 30322. E-mail medjnw{at}emory.edu
| Abstract |
|---|
|
|
|---|
Methods and Results Balloon injury was performed on porcine
coronary arteries, followed immediately by ionizing radiation
using either a source train of 90Sr/Y or 192Ir
seeds designed to deliver 14 or 28 Gy at a depth of 2 mm from the
source. The animals were killed 3, 7, or 14 days after injury.
Bromodeoxyuridine was administered 24 hours before euthanasia to label
proliferating cells. Cell proliferation was significantly reduced on
day 3 in the adventitia and media of the irradiated vessels compared
with controls. Two weeks after injury, there were fewer
-actinpositive myofibroblasts in the adventitia of the irradiated
vessels than in nonirradiated controls, and morphometric
analysis indicated that the vessel perimeter of the irradiated
vessels was significantly larger than in controls. Together, these
results suggest a positive effect of intravascular irradiation on
vascular remodeling. Apoptosis was estimated by terminal
transferase dUTP-biotin nick-end labeling (TUNEL) 3 and 7 days after
injury. TUNEL-labeled cells were found primarily in the adventitia at
the medial tear, but no differences were detected between irradiated
and control vessels.
Conclusions These studies suggest that intracoronary radiation primarily inhibits the first wave of cell proliferation in the vessel wall and demonstrates a favorable effect on late remodeling by preventing adventitial fibrosis at the injury site.
Key Words: restenosis remodeling proliferation angioplasty radiation
| Introduction |
|---|
|
|
|---|
- and ß-emitting radioactive sources,
including 192Ir,1 2 3 90Sr/Y, and
90Y.4 5 6 Similar results have been reported on
the prevention of lesion development in stented vessels either by
intravascular irradiation at the time of stent placement7
or in studies using radioactive stents.8 9 The effect on
lesion development appears to be stable and long-lasting, and at least
two of the pig studies have been carried out to 6 months with good
results.2 4 Currently, there are several clinical trials
in progress that will assess the effect of intravascular irradiation on
clinical restenosis. The use of endovascular irradiation for reducing restenosis after angioplasty is derived from the concept that restenosis has many similarities to wound healing. The use of radiation to modify the wound-healing response has been well documented.1 2 10 Clinically, low-dose radiation is in use for a number of different proliferative conditions, including the prevention of keloids11 12 13 and heterotopic bone formation.14 15
Many different mechanisms have been proposed to explain the sequence of events leading to arterial narrowing or restenosis after angioplasty. Previously, the major focus had been on the medial smooth muscle cells, which were thought to give rise to a restenosis lesion. It is well documented in the rat and rabbit injury models that balloon injury stimulates the proliferation of medial smooth muscle cells, which migrate to the intima, where they continue to proliferate and produce matrix proteins, forming a neointima.16 17 18 19 However, such injuries rarely produced a narrowing of the arterial lumen that is associated with clinical restenosis. More recently, it has been suggested that geometric remodeling may be more important than neointima formation in the restenosis process. This is supported by intravascular ultrasound studies in patients20 21 22 23 and a number of animal studies,20 21 24 all of which indicate that there is a reduction in the diameter of the external elastic lamina after angioplasty and that this decrease in the overall vessel size is a better correlate with the degree of luminal narrowing than the size of the intimal mass.
We have recently demonstrated that angioplasty of porcine
coronary arteries stimulates adventitial myofibroblast
proliferation, leading to a fibrotic response in the
adventitia.25 These cells show increased synthesis of
-smooth muscle actin25 and nonmuscle myosin heavy
chain26 and accumulate in the adventitia surrounding the
injury site. In healing dermal wounds, similar cells are involved in
the process of scar contraction.27 28 We hypothesize that
the adventitial myofibroblasts may constrict the injured vessel in a
similar fashion, thus contributing to the process of geometric
remodeling and late lumen loss after angioplasty.25
In the present study, we have undertaken a series of experiments to determine the effect of ionizing radiation on cell proliferation in the media and adventitia, arterial remodeling, and apoptosis to understand the mechanisms by which ionizing radiation prevents vascular lesion formation after balloon injury in porcine coronary arteries.
| Methods |
|---|
|
|
|---|
Balloon Overstretch Injury and Radiation Treatment
The model of overstretch injury has been described
previously.29 30 Seventy-two female domestic pigs
(Sus scrofa, 18 to 27 kg) were given aspirin (325 mg) 1 day
before and on the day of the procedure. They were sedated with a
combination of tiletamine HCl (10 mg/kg IM) and atropine (0.6
mg/kg IM), and general anesthesia was maintained
with 1% to 2% Isothane with a Harvard respirator.
After placement of an 8F introducer sheath in the right femoral artery by surgical cutdown, each animal received a single dose of heparin (200 U/kg) and bretylium tosylate (2.5 mg/kg). Under fluoroscopic guidance, an 8F hockey stick guiding catheter was positioned in the left coronary ostium. After the intracoronary administration of nitroglycerin (200 µg), coronary angiography was performed in the 45° left anterior oblique and 45° right anterior oblique views and recorded by cineangiography (Phillips Cardiodiagnost).
Balloon overstretch injury was performed with a 3.5-mm clinical angioplasty balloon positioned in the proximal segments of the left anterior descending and left circumflex arteries and inflated to 10 atm three times for 30 seconds in each artery. Inflation periods were separated by 1-minute deflation periods to restore coronary perfusion. After the completion of the third inflation, the angioplasty balloon was withdrawn and additional nitroglycerin (200 µg) was administered to limit coronary spasm. Repeat angiography was then performed to assess vessel patency and degree of injury.
One of the injured coronary arteries in each swine was assigned
randomly to receive radiation treatment with either a ß- or
-emitting source train. In 19 of the animals, a ß-source was
positioned at the angioplasty site of the assigned artery within a 5F
delivery catheter (Novoste Corp) introduced over a flexible 0.014-in
wire. After the guidewire was withdrawn, a 2.5-cm-long train with five
seeds of 90Sr/Y was positioned at the site of injury in the
target vessel by cinefluoroscopic visualization within the delivery
catheter. The seeds were left in place for a period sufficient to
deliver the assigned dose (14 or 28 Gy) to a depth of 2 mm (180 to
360 seconds). In 4 pigs, the radiation treatment was administered with
192Ir as follows. A 4F perfusion-delivery catheter (USCI)
was introduced over a flexible 0.014-in wire across the injury site of
the assigned artery, the guidewire was withdrawn, and a 3.0-cm source
train with nine seeds of 192Ir was positioned at the site
of the injury and was left in place for a period sufficient to deliver
a dose of 28 Gy to a depth of 2 mm (28 to 58 minutes, depending on
the source activity). All animals receiving 192Ir were part
of the 28-Gy dose group killed 3 days after angioplasty for BrdU
analysis, such that 4 of 6 animals in that group received this
form of radiation. Data from both ß- and
-irradiated vessels were
combined, because previous work indicated that both forms of radiation
produced similar results with respect to lesion formation if the dose
was the same.5 31 After irradiation, the delivery and
guiding catheters were removed and the femoral cutdown was repaired.
Nitroglycerin ointment was administered topically, and
the animals were returned to routine care.
Calculation of Radiation Dose
The treatment times for 192Ir were determined in
standard fashion by entering the activity and length of the
192Ir ribbon (Best Industry Inc) into a commercial
radiation treatment planning system (CMS Modulex) and calculating the
dose rate at 2.0 mm from the center of the source train. The dose
rate around the 2.5-cm 90Sr/Y source train was calculated
with Monte Carlo electron transport code (ITS). The energy spectrum of
90Sr/Y was obtained from Cross et al.32 No in
vivo dosimetry was performed. The delivery systems for the ß- and
-emitters were not centered, and therefore there was potential
variability in the dose delivered to the arterial wall.
BrdU Injection and Tissue Preparation
The effect of radiation on cell proliferation was determined by
BrdU injections and immunohistochemistry in 29 pigs killed either 3
(n=17) or 7 (n=12) days after injury. BrdU (Sigma Chemical Co) was
administered via the ear vein of the pigs in three doses of 50
mg/kg at 24, 16, and 8 hours before tissue harvest to label the
proliferating cells. The animals were killed with an overdose of
barbiturate, the hearts removed, and the injured arteries perfused in
situ with saline followed by 4% paraformaldehyde in
NaPO4 buffer (pH 7.4) at 100 to 110 mm Hg pressure
for 5 minutes. The arteries were then dissected from the heart and
immersed overnight in 15% sucrose-PBS. The following day, the vessels
were divided into serial 3.0-mm segments and frozen in liquid nitrogen
embedded in optimal cutting temperature compound (O.C.T., Miles
Laboratories) in a manner allowing the serial reconstruction of each
vessel. Histological analysis was performed on
6-µm cryosections collected onto glass slides (Fisher SuperFrost
Plus).
TUNEL Assay
Apoptosis was estimated by the TUNEL assay, which relies
on the incorporation of labeled dUTP at sites of DNA
breaks.33 Tissue sections were incubated in 4.0%
paraformaldehyde for 20 minutes, followed by rinsing in
PBS and treatment with 0.1% triton/0.1% sodium citrate for 2 minutes
at 4°C before addition of the TUNEL reaction mixture containing TdT
and fluorescein-labeled UTP as described by the
manufacturer (In situ Cell Death Detection kit, Alkaline Phosphatase;
Boehringer Mannheim) and incubation for 60 minutes at 37°C.
The slides were then washed in PBS, and 100 µL of converter-AP
(anti-fluorescein antibody linked to an alkaline
phosphatase reporter; Boehringer Mannheim) was added to the
sections, which were then incubated in a humid chamber for 30 minutes
at 37°C. The slides were again washed in PBS, followed by a final
wash in 100 mmol/L Tris (pH 8.2). The presence of alkaline
phosphatase was detected with Vector Blue substrate as described by the
manufacturer (Vector Laboratories). The slides were subsequently washed
in distilled water and lightly counterstained with hematoxylin.
Positive control slides, treated with 200 µg/mL DNase I
(Promega) for 10 minutes at room temperature, and negative control
slides in which the TdT was omitted from the reaction buffer were
included in every experiment.
Immunohistochemistry
BrdU-containing cells were detected in the tissues by
immunohistochemistry using a specific BrdU monoclonal antibody as
described.25 Tissue sections were predigested with
proteinase K (1 µg/mL) and 4N HCl, washed in PBS, and
incubated with the anti-BrdU antibody (1/20 dilution; Dako) for 60
minutes at room temperature. The BrdU antibody was then detected with
biotinylated horse anti-mouse IgG (1/400 dilution; Vector Laboratories)
and the ABC-AP kit with Vector Red substrate as described by the
manufacturer (Vector Laboratories), followed by counterstaining with
hematoxylin. Immunohistochemistry using an
-smooth muscle
actinspecific antibody was used to identify myofibroblasts in the
adventitia as previously described25 (SM1, 1/800 dilution;
Sigma Chemical) with biotinylated horse anti-mouse IgG and the ABC-AP
kit with Vector Red.
Image Analysis
The counting of cells labeled by BrdU immunohistochemistry or
the TUNEL assay was performed as previously described.25
Color video images of 280x360-µm fields were captured and digitized
with a x25 objective with a Sony DXC-760MD video camera, a RasterOps
24XLTV video card, and Media Grabber software on a Macintosh Quadra 950
computer. The region of interest of each captured image was indicated
by the operator and its area automatically determined by the computer
after standardization with a microscale slide. The digital images were
then analyzed by splitting the color images into their red and
blue components for the determination of blue (hematoxylin-positive)
and red (BrdU- or TUNEL-positive) cells, respectively, with the IP Lab
Spectrum software package (Signal Analytics Corp). Positive and
negative cells of each color were differentiated by setting threshold
values and cell size discriminators that yielded the best
identification of positive cells as judged by the operator. Each
analysis was subjected to critical examination by a blinded
operator, and cells were added or removed from the computer count to
accurately reflect the number of red or blue cells in the microscope
field. This analysis has been validated by comparison to manual
counts alone and yields essentially the same results with a correlation
of r=.892 (P=.0005). Consistency was
determined throughout the computer analysis by repeated
analysis of five control fields from a control BrdU-labeled
vessel that showed a variation of <3%.
Data obtained from both the left anterior descending and circumflex
arteries were combined. Two cross sections from each vessel
3
mm apart were stained for either BrdU or TUNEL and counted. Cell
proliferation was analyzed at x250 magnification in five
regions in each vessel as follows: region 1, in the media adjacent to
the medial tear; region 2, in the media on the side opposite the medial
tear; region 3, in the adventitia adjacent to the medial tear; region
4, in the adventitia on the side opposite the medial tear; and region
5, in the intima defined as the luminal side of the external elastic
lamina between the torn ends of the media. All the cells in each region
were counted; this meant that depending on the size of the vessel, two
to four fields at x250 magnification were captured and
analyzed in each region. The percentage of proliferating cells
was calculated (total number of BrdU-labeled cells/total number of
hematoxylin-labeled cellsx100) in each region and averaged over the
number of fields and the number of cross sections examined for each
vessel. The vessel means, determined for each region of each vessel at
each time point, were then used as individual data points for
statistical comparison.
Only those vessels with distinct medial tears corresponding to the injury classification II to III (a clear break in the internal elastic lamina and media with a 25% to 50% gap in the media without compromising the external elastic lamina) as previously described34 were analyzed. This eliminated from the study those vessels in which the balloon catheter failed to break the internal elastic lamina and media or in which multiple fractures of the media were found. Thrombus formation was not a significant feature in the vessels, although hemorrhage into the adventitial space localized to the region of injury was seen consistently in all vessels examined.
Determination of Vascular Remodeling
To assess the effect of intravascular brachytherapy on
arterial remodeling after angioplasty, we measured changes
in the artery size by computer-based morphometry. Forty-three animals
underwent balloon injury as described, followed by either no treatment
(n=20 arteries) or exposure to either 14 Gy (n=19 arteries) or 28 Gy
(n=4 arteries) intravascular irradiation. The animals were killed 14
days after injury, and the vessels were harvested, pressure-perfused
with 4.0% paraformaldehyde, and embedded in paraffin.
Cross sections of these vessels were sectioned and stained for elastin,
and the vessel perimeter and luminal area were measured by computerized
morphometry with an IBM-based system (Bioscan 2, Thomas Optical
Measurement System Inc) as previously described.2 5 The
distribution of myofibroblasts in the adventitia surrounding the injury
site was also examined in these vessels by immunohistochemistry with an
-smooth muscle actinspecific antibody (SM1). Previous studies from
our laboratory indicated that myofibroblasts containing
-smooth
muscle actin develop a fibrotic scar in the adventitia surrounding the
injury site.25
Statistical Analysis
Data are expressed as mean±SEM. The numbers of proliferating
cells as determined by BrdU immunohistochemistry and computer-aided
image analysis were compared by one-way ANOVA and the
Tukey-Kramer multiple comparison test with the InStat statistical
package (GraphPad Software, version 2.01). The histomorphometric
measurements were compared by Student's t tests with
Bonferroni correction. Statistical significance was established at the
95% confidence level (P<.05).
| Results |
|---|
|
|
|---|
|
|
Careful examination of individual ß-irradiated vessels on a
segment-by-segment basis through the injury and irradiation site
demonstrated some variability in the number of proliferating cells in
adjacent vessel segments as close as 3 mm apart (Fig 3
). For example, in one section, 38.1%
of the adventitial cells were BrdU positive, whereas in a vessel
segment in the next block only 3 mm away, 8.5% of the adventitial
cells were proliferating. Although the total mean percentage of
proliferating cells analyzed statistically across all of the
segments indicated that there was a significant reduction in
proliferation by radiation, it should be realized that this
represents an average of irradiated segments from the same
animal showing both a very high and a very low rate of proliferation.
It is likely that this represents a problem with the early
prototype versions of the radiation sources delivering the radiation
evenly across the injured arterial segment rather than a
heterogeneity of the effect of radiation on cell
proliferation in these tissues. This is supported by our evaluation of
the distribution of radiation emanating from the source train in
these prototype catheters. The 90Sr/Y sources were left in
place in a Lucite storage device after these experiments were
completed. Radiation released from these sources interacted with the
Lucite, producing a brown discoloration that is seen visually and shows
the radiation effect to be segmental rather than continuous (Fig 3C
).
|
Seven days after angioplasty, no differences in cell proliferation in
the media or adventitia between the irradiated and control arteries
were detected, although there was an apparent reduction in the degree
of intimal development at this time point (Fig 2
). Morphometric
analysis indicated that the average intimal area per cross
section was significantly smaller in the 14-Gy (0.073±0.016
mm2) and 28-Gy (0.057±0.007 mm2) groups
than in controls (0.144±0.014 mm2) (P<.05
and P<.01, respectively), although there was no difference
in the density of intimal cells (number of hematoxylin-stained
nuclei/mm2) between the three groups (Table 1
).
|
Apoptosis
Apoptosis was estimated by TUNEL labeling at 3 and 7 days
after balloon injury, and the number of apoptotic cells was
counted by computer-based image analysis (Fig 4
). These studies suggested that there
was histochemical evidence of apoptosis in all of the injured
vessels. However, there were no quantitative differences in the amount
of labeling among irradiated and control vessels in any region examined
on either day 3 or day 7. Three days after angioplasty, the number of
TUNEL-labeled cells was greatest in region 5 along the luminal surface
of the external elastic lamina, which was exposed by the tearing of the
medial wall at the time of angioplasty. Morphological examination of
these cells suggests that these were neutrophils that had accumulated
at the injury site. Many TUNEL-labeled cells were also detected in the
adventitia beneath the external elastic lamina between the broken ends
of the media and in the torn ends of the medial wall (Fig 5
). These are all sites of the greatest
amount of cell proliferation at this time as determined by BrdU
immunohistochemistry.
|
|
The cell density, calculated as the mean number of hematoxylin-stained
nuclei per square millimeter, was examined in control and irradiated
vessels. There were no significant differences in cell density between
the control, 14-Gy, or 28-Gy arteries 3 days after injury in any
portion of the media or adventitia (Table 1
). Seven days after
angioplasty, there appeared to be significantly more cells per square
millimeter in region 2 (normal media on the side opposite the break) of
the 28-Gytreated vessels compared with either control or 14-Gy
treatment (P<.01), but no other significant differences in
cell number in the intima, media at the break site, or adventitia were
found.
Effect on Remodeling
The recruitment of adventitial myofibroblasts to the injury site
was assessed by immunohistochemistry for
-smooth muscle actin on
days 3, 7, and 14 after injury. There was a clear difference in the
extent of adventitial
-actin staining in the irradiated vessels
compared with control vessels at all time points (Fig 6
), suggesting an inhibition of
adventitial fibrosis by the radiation treatment. Morphometric
analysis among 18 specimens 2 weeks after balloon injury with
and without radiation confirmed that there was a larger vessel
perimeter in the irradiated vessels (Table 2
).
|
|
| Discussion |
|---|
|
|
|---|
-smooth muscle actin staining in the irradiated vessels at 3, 7, and
14 days after angioplasty. We hypothesize that this represents
a reduction in the distribution of myofibroblasts in the adventitia
surrounding the injury site. Together, these results suggest that
radiation treatment inhibits vascular lesion formation by reducing the
first wave of cell proliferation in the media and adventitia and
reducing the adventitial fibrosis, which may be the underlying cause of
geometric remodeling associated with clinical restenosis. A number of studies support the hypothesis that cell proliferation is the key contributor to vascular narrowing after angioplasty,35 36 37 38 but agents that inhibit cell proliferation do not necessarily reduce the size of the ultimate vascular lesion that develops. Proliferation in the arterial wall after angioplasty can be broken down into two components: early or first-wave proliferation occurs in the medial wall within 24 to 72 hours after injury; late or second-wave cell proliferation occurs in the intima and may continue for as long as 2 months after injury. Previous studies have shown successful reduction in first-wave proliferation (ie, by treatment with FGF antibodies), but such treatment did not reduce the size of the neointima.39 It has been hypothesized that there are multiple pathways that stimulate the growth of the neointima, such that inhibition of one pathway for growth stimulation may be replaced by another. Thus, the few cells that proliferated in the media in the presence of the FGF antibody migrated to the intima and continued to grow there, independent of FGF, giving rise to the lesion. Presumably, this ensures that proper repair mechanisms remain in place after vascular injury. In contrast, intravascular irradiation at the time of angioplasty effectively reduced first-wave proliferation 3 days after injury but had no effect on the second wave of growth, measured on day 7, in the intima. Yet this treatment successfully reduced lesion size measured not only at an early time point 2 weeks after angioplasty2 5 but 6 months later as well.2 4 This could mean one of two things: either intimal proliferation is not important in generating the final lesion or radiation may have caused an earlier termination of intimal proliferation sometime after day 7, the time point examined in this study. Given the present knowledge about the effect of radiation on cell growth in other systems, the latter hypothesis seems more tenable. Additional work will have to be done to determine whether intimal proliferation is suppressed at an earlier time point in irradiated versus nonirradiated vessels.
There was some variability in cell proliferation within the adjacent
segments of an individual irradiated artery. These occurred primarily
when radiation with the pure ß-emitter 90Sr/Y was applied
and may be related to the lower penetration properties of the
ß-radiation compared with the
-radiation combined with
heterogeneous distribution of radiation emanating from the
source train. It is possible that inhomogeneous packing of
the radioactivity in the seeds caused some of this variability.
Alternatively, the thick end caps placed on the seeds used in the first
prototype version of the device resulted in spaces between the
radioactive sources in the train, such that a lower dose was delivered
to the tissues positioned at these junctions. Consequently, some
segments of the vessel did not receive a sufficient radiation dose to
inhibit cell proliferation. Alternatively, malpositioning of the source
train at the injury site may also have spared a portion of the vessel
from exposure to radiation. An examination of the Lucite block in which
the source train was stored for several weeks suggests that the former
hypothesis is correct. This has been corrected in latter versions of
the radiation sources. These findings stress the importance of accuracy
in positioning the source at the angioplasty site and the need to
design the delivery device in such a way as to ensure the even
distribution of radiation into the surrounding tissues. These results
also indicate that intravascular radiation therapy using
90Sr/Y produces highly localized effects in the surrounding
vessel. This may be important in that in clinical use, the radiation
should not damage deep adventitial structures. Thus, a large population
of resident adventitial cells will not have been exposed to high doses
of radiation and should be capable of responding to maintain vessel
integrity in the setting of a subsequent injury or cellular loss at
that site. We hypothesize that this may reduce the potential for
aneurysmal dilation of the vessel over long periods of
time.
These studies suggest that it is important that a sufficient dose of
radiation be delivered to the adventitial structures at the injury site
to prevent arterial remodeling and restenosis. We
have previously presented data suggesting that adventitial
myofibroblasts may migrate into the developing neointima
across the external elastic lamina and contribute to the mass of the
lesion that develops after balloon overstretch injury of porcine
coronary arteries.25 In addition, the
proliferation of adventitial cells produces a fibrotic response around
the injured vessel and probably contributes to the geometric remodeling
associated with balloon injury. In the present study, we directed
our dose not to the intimal surface (ideally calculated 1.5 mm
from the center of the source train) but rather to a depth sufficient
to ensure an adequate dose to the adventitia surrounding the injury
site (2.0 mm). This reduced the proliferation of the adventitial
myofibroblasts and the recruitment of
-smooth muscle actinpositive
cells around the vessel. We hypothesize that the reduction of
adventitial fibrosis prevented negative arterial
remodeling, resulting in a larger vessel perimeter of the irradiated
vessels. This may also have had the favorable secondary effect of
inhibiting migration of adventitial myofibroblasts across the external
elastic lamina into the neointima.
Apoptosis is also known as programmed cell death and is distinct from necrosis or other forms of cell death.40 Radiation therapy of tumors has been reported to cause signs of apoptotic death within 3 hours. If a tumor responds rapidly to a relatively low dose of radiation, it generally means that apoptosis is involved, because the process peaks at 3 to 5 hours after irradiation. Susceptibility to the induction of apoptosis may also be an important factor determining radiosensitivity, because apoptosis appears to be prominent early in radiosensitive mouse tumors and essentially absent in radioresistant tumors. It has been suggested that apoptosis is the dominant form of cell death in lymphoma cells treated with photodynamic therapy and that this process occurs more rapidly than after x-irradiation.41 42 43
Apoptosis is also a feature of human vascular pathology, including restenotic lesions.44 Coronary arterial specimens of patients with restenotic lesions retrieved via atherectomy demonstrated a high level of apoptosis, and it was suggested that apoptosis may modulate the cellularity of lesions that produce vascular obstruction. Balloon injury of rat carotid arteries also stimulates apoptosis in the medial wall and neointima in regions of greatest cell proliferation.45 These observations are similar to our finding of TUNEL-positive cells at the sites of greatest cell proliferation in the media and adventitia of the injured porcine coronary arteries. However, radiation did not increase TUNEL labeling either 3 or 7 days after injury compared with control vessels. Although this suggests that radiation may not work through an induction of apoptosis, these studies do not eliminate the possibility that radiation may induce an increase in apoptosis much earlier, within hours of treatment. Furthermore, it should be pointed out that TUNEL labeling alone is not a perfect measure of apoptosis and tends to overestimate actual rates of apoptosis in normal and atherosclerotic vessels.46 Additional studies will have to be done with additional markers of apoptosis at earlier time points to determine what proportion of the TUNEL-positive cells is beginning programmed cell death as a result of the radiation therapy.
Arterial remodeling has been described as a major
contributor to the restenosis process. Several authors have
suggested that vascular remodeling after angioplasty is more important
than neointima formation in late luminal
narrowing.20 21 Others relate vascular remodeling to the
device used for the arterial dilation.47 48 In
the present study, we observed an increase of the vessel perimeter
and the luminal area of irradiated vessels compared with controls, with
a positive relationship between the dose and vessel size. This
morphometric observation is supported by the reduction in
-smooth
muscle actin staining of adventitial myofibroblasts in the irradiated
vessels. Therefore, we hypothesize that intravascular irradiation had a
positive effect on vascular remodeling because of the reduction in the
recruitment of adventitial myofibroblasts in the adventitia at the
injury site that prevented constriction. Intravascular irradiation may
be a substitute for intracoronary stenting if chronic vascular
constriction after angioplasty is diminished by radiation.
These preliminary findings suggest that intracoronary radiation
prevents vascular lesion formation after coronary intervention
by reducing cell proliferation in the media and adventitia 3 days after
injury. In addition, intravascular radiation may contribute to positive
remodeling and reduction of vessel constriction by reduction of
-smooth muscle actincontaining cells in the adventitia. Additional
work is needed to determine the effect of radiation on cell migration
from the media or adventitia to the neointima and to
determine the effects of radiation on normal and atherosclerotic
vessels.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received February 12, 1997; revision received April 2, 1997; accepted April 13, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. G. Touchard and R. S. Schwartz Preclinical Restenosis Models: Challenges and Successes Toxicol Pathol, January 1, 2006; 34(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Sindermann, V. Verin, J. W Hopewell, H. P. Rodemann, and J. H Hendry Biological aspects of radiation and drug-eluting stents for the prevention of restenosis Cardiovasc Res, July 1, 2004; 63(1): 22 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cheneau, M. C. John, J. Fournadjiev, R. C. Chan, H.-S. Kim, L. Leborgne, R. Pakala, H. Yazdi, A. E. Ajani, R. Virmani, et al. Time Course of Stent Endothelialization After Intravascular Radiation Therapy in Rabbit Iliac Arteries Circulation, April 29, 2003; 107(16): 2153 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krueger, P. Landwehr, M. Bendel, M. Nolte, H. Stuetzer, R. Bongartz, M. Zaehringer, G. Winnekendonk, A. Gossmann, R.-P. Mueller, et al. Endovascular Gamma Irradiation of Femoropopliteal de Novo Stenoses Immediately after PTA: Interim Results of Prospective Randomized Controlled Trial Radiology, August 1, 2002; 224(2): 519 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maehara, N. S. Patel, L. B. Harrison, N. J. Weissman, A. B. Bui, H.-S. Kim, A. E. Ajani, M. T. Castagna, T. L. McMillan, N. Yang, et al. Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: A volumetric intravascular ultrasound dosimetric study J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1937 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kozuma, M.A. Costa, W.J. van der Giessen, M. Sabate, J.M.R. Ligthart, V.L.M.A. Coen, I.P. Kay, A.J. Wardeh, A.H.M. Knook, P.J de Feyter, et al. Initial observation regarding changes in vessel dimensions after balloon angioplasty and stenting followed by catheter-based {beta}-radiation. Is stenting necessary in the setting of catheter-based radiotherapy? Eur. Heart J., April 2, 2002; 23(8): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Castagna, G. S. Mintz, R. Waksman, J. M. Ahmed, A. Maehara, A. E. Ajani, A. B. Bui, L. F. Satler, W. O. Suddath, K. M. Kent, et al. Comparative Efficacy of {gamma}-Irradiation for Treatment of In-Stent Restenosis in Saphenous Vein Graft Versus Native Coronary Artery In-Stent Restenosis: An Intravascular Ultrasound Study Circulation, December 18, 2001; 104(25): 3020 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant Circ. Res., December 7, 2001; 89(12): 1111 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Teirstein and R. E. Kuntz New Frontiers in Interventional Cardiology: Intravascular Radiation to Prevent Restenosis Circulation, November 20, 2001; 104(21): 2620 - 2626. [Full Text] [PDF] |
||||
|
|